CLINICAL_TRIALS
trial_result
· 2025-10-03
Clinical Trial Update: Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm [Phase 2]
Summary
A Phase 2 exploratory study of dipraglurant (ADX48621) for blepharospasm and dystonia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Addex Pharma S.A. | Conditions: Blepharospasm, Dystonia | Phase 2 | Status: COMPLETED